Royal Sense Ltd
Founded in 2023, Royal Sense Limited deals in Medical Equipment, Surgical Instruments, Surgical Consumables, Laboratory Equipment, Laboratory Reagents, Medical Disposables and Diagnostic Kits.[1]
- Market Cap ₹ 135 Cr.
- Current Price ₹ 253
- High / Low ₹ 316 / 104
- Stock P/E 34.1
- Book Value ₹ 42.0
- Dividend Yield 0.00 %
- ROCE %
- ROE %
- Face Value ₹ 10.0
Pros
- Company is almost debt free.
Cons
- Stock is trading at 6.02 times its book value
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Half Yearly Results
Consolidated Figures in Rs. Crores / View Standalone
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2024 | TTM | |
|---|---|---|
| 17.80 | 39.82 | |
| 15.54 | 34.40 | |
| Operating Profit | 2.26 | 5.42 |
| OPM % | 12.70% | 13.61% |
| 0.03 | 0.06 | |
| Interest | 0.09 | 0.10 |
| Depreciation | 0.01 | 0.02 |
| Profit before tax | 2.19 | 5.36 |
| Tax % | 27.85% | |
| 1.59 | 3.97 | |
| EPS in Rs | 3.24 | 8.10 |
| Dividend Payout % | 0.00% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | % |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | % |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| 1 Year: | % |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| Last Year: | % |
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2024 | Sep 2024 | |
|---|---|---|
| Equity Capital | 4.90 | 4.90 |
| Reserves | 13.32 | 15.69 |
| 1.61 | 1.55 | |
| 0.95 | 1.89 | |
| Total Liabilities | 20.78 | 24.03 |
| 0.05 | 0.06 | |
| CWIP | 0.00 | 0.00 |
| Investments | 0.42 | 0.43 |
| 20.31 | 23.54 | |
| Total Assets | 20.78 | 24.03 |
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2024 | |
|---|---|
| -3.87 | |
| -0.52 | |
| 13.13 | |
| Net Cash Flow | 8.74 |
Ratios
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2024 | |
|---|---|
| Debtor Days | 66.03 |
| Inventory Days | 103.54 |
| Days Payable | 1.25 |
| Cash Conversion Cycle | 168.32 |
| Working Capital Days | 215.10 |
| ROCE % |
Documents
Announcements
-
Announcement Under Regulation 30 Of SEBI (Listing Obligation And Disclosure Requirements), Regulation, 2015
1d - Royal Sense Limited receives US FDA approval for multiple medical devices.
-
Intimation Under Regulation 30 Of SEBI
1d - Royal Sense Limited signs distribution agreements with Zepto and Blinkit.
-
Update on board meeting
1 Feb - Revised board meeting for TTG Innovations merger.
-
Board Meeting Intimation for Prior Intimation For The Board Meeting To Be Held On 6Th February, 2025
31 Jan - Board meeting to consider amalgamation with TTG Innovations.
-
Disclosure Under Regulation 30 Of The SEBI (LODR) Regulations, 2015 Regarding Purchase Of Property.
15 Jan - Company purchased property for factory and corporate office.
Business Profile[1] Royal Sense Ltd. (RSL) supplies materials to hospitals, laboratories, institutions and clinics for health services.